MeVox
Protection by design
London, United Kingdom · Founded 2020 · $6.1M raised
- Headquarters
- London
- Employees
- 1–10
- Founded
- 2020
- Business Model
- B2B
- Website
- mevoxltd.com
- Total Funding
- $6.1M
- Last Round
- $6.1M Venture Round
- Rounds
- 1
About
Biotech company developing conformationally precise vaccines using cutting-edge antigen design and molecular engineering.
Summary
MeVox is a Biotech company based in London, United Kingdom, founded in 2020. It has raised $6.1M in total across 1 round. Investors include Morningside Group.
Tech & App Stack
4 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Unknown
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.